reports
ANZ Group Holdings Ltd: 2 directors
Two Directors at ANZ Group Holdings Ltd sold after exercising options/sold 32,198 shares at between 34.685AUD and 38.764AUD. The significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by ...
- MarketLine Department
Suncorp Group Ltd - Company Profile and SWOT Analysis
Summary Suncorp Group Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Suncorp Group Limited (Suncorp) is a Trans-Tasman insurance group. The group's primary activities involve providing a range of insurance products and services. These include home, contents, motor, boa...
- Maria Vara
- Oscar Haffen Lamm
End of coverage
From 5th February, we will no longer include in our research universe:Adaptimmune, ALK, argenx, Autolus, Cellectis, Galapagos, Hansa Biopharma, Heidelberg Pharma, Immatics, Immunocore, Ipsen, Moonlake Immunotherapeutics, Pharvaris, UCB, Vivoryon Therapeutics, Zealand Pharma, Nicox, GenSight Biologi
CLLS CELLECTIS ADS
ADAP ADAPTIMMUNE THERAPEUTICS ADS
ANZ AUSTRALIA AND NEW ZEALAND BANKING GROUP LIMITED
HPHA HEIDELBERG PHARMA AG
COX NICOX SA
UCB UCB S.A.
HNSA HANSA BIOPHARMA AB
SIGHT GENSIGHT BIOLOGICS SA
ALSEN SENSORION SAS
ALKb ALK-ABELLO
ARGX ARGEN-X SE
AUTL AUTOLUS THERAPEUTICS ADS
IMCR IMMUNOCORE HOLDINGS ADS
PHVS PHARVARIS NV
MLTX MOONLAKE IMMUNOTHERAPEUTICS
IMTX IMMATICS
GLG GALAPAGOS
VVY VIVORYON THERAPEUTICS
- Charlotte Cervin
- Elisabeth Rudman
- Maria Rivas Escrigas
Australian Banks: Strong H1 2023 Results On Net Interest Income Growth...
DBRS Morningstar has published a commentary discussing large Australian banks’ recent H1 2023 results, including Australia and New Zealand Banking Group Limited, National Australia Bank Limited, and Westpac Banking Corporation. Key points include: • The three large Australian banks reported solid results in the first half of 2023 primarily driven by strong net interest income growth on the back of higher interest rates and solid new lending volume growth. • Credit costs increased for all th...
- Charlotte Cervin
- Elisabeth Rudman
- Maria Rivas Escrigas
- Elisabeth Rudman
- Maria Rivas Escrigas
- Charlotte Cervin
- Elisabeth Rudman
- Maria Rivas Escrigas
Japanese & Australian Banks: Moderate Exposure to China, Hong-Kong and...
DBRS Morningstar has released a commentary focusing on Japanese and Australian banks’ exposures to China, Taiwan and Hong Kong. Key points include: • In a scenario of an escalation in tensions surrounding Taiwan’s status, indirect risks could have some implications for Japanese and Australian banks as they have some operations in these regions. • The total credit exposure of Japanese and Australian banks to China, Hong Kong and Taiwan is moderate representing a relatively low proporti...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.